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CASE REPORT
Birt-Hogg-Dubé Syndrome, a Rare Case in Korea 
Confirmed by Genetic Analysis
Won Woong Shin, Yoo Sang Baek, Tae Seok Oh, Young Soo Heo, Soo Bin Son, Chil Hwan Oh, 
Hae Jun Song
Department of Dermatology, College of Medicine, Korea University, Seoul, Korea
Simple benign tumors can present as part of a syndrome with 
substantial mortality. Fibrofolliculomas are benign skin 
tumors most often associated with the Birt-Hogg-Dubé 
syndrome (BHDS). The most life-threatening complication of 
this syndrome is renal cancer and other major features 
include multiple lung cysts and spontaneous pneumothorax. 
We present the case of a 54 year-old man with multiple 
flesh-colored papules on his face confirmed histologically as 
fibrofolliculomas. He had a history of recurrent pneumo-
thorax and chest computed tomography showed multiple 
lung cysts. To confirm the diagnosis of BHDS, we conducted 
gene analysis that revealed a single nucleotide duplication in 
the folliculin (FLCN) gene (Exon 11, C.1285dupC). BHDS 
confirmed by the FLCN gene mutation is rarely reported in 
Korea. Appropriate investigation is recommended whenever 
a patient with benign skin tumors is encountered. (Ann 
Dermatol 23(S2) S193∼S196, 2011)
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INTRODUCTION
Birt-Hogg-Dubé syndrome (BHDS) is an autosomal domi-
nant condition characterized clinically by fibrofollicu-
lomas, pulmonary cysts, spontaneous pneumothorax and 
renal cancer. It is caused by germline mutations in the 
folliculin (FLCN) gene, detection of which confirm the 
diagnosis, but no correlation has been revealed between 
phenotypes and mutations. We report a 54-year-old male 
BHD patient with multiple, tiny, flesh-colored papules on 
both cheeks and multiple lung cysts with recurrent 
pneumothorax of the left lung. 
CASE REPORT
A 54-year old man with asymptomtic, tiny, multiple, 
flesh-colored papules on both cheeks (Fig. 1) was referred 
to us from the cardiothoracic surgery department, where 
he had been treated for recurrent pneumothorax of the left 
lung. He did not remember the onset of the lesions, but 
stated that the number was increasing. He had no special 
medical or family history. The papules were thought to be 
sebaceous hyperplasia or verruca plana and a punch 
biopsy was performed. The specimen showed an epi-
thelial cord and fibrous stroma in the dermis and an 
anastomosing band from follicular epithelium (Fig. 2). A 
diagnosis of fibrofolliculoma was made, which is the 
major feature of BHDS.
There was no family history of the skin lesions, lung 
disease, and of benign or malignant tumors. Furthermore, 
multiple variable-sized lung cysts were found on his chest 
following computed tomographic scan and a right renal 
cyst 2 cm in diameter was found on abdominal sonogra-
phy (Fig. 3). Molecular analysis of FLCN was performed 
after informed consent from the patient. Sequencing 
revealed a single nucleotide frameshift duplication oc-
curring within the polycytosine tract located in exon 11, 
c.1285dupC (p.H429Pfs*27), resulting in a change of the 
429th amino acid from histidine to proline in the FLCN WW Shin, et al
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Fig. 1. Clinical features of fibro-
folliculomas.
Fig. 2. Histopathology of fibrofolliculoma. (A) H&E stain, ×40. (B) H&E stain, ×100.
Fig. 3. Imaging studies. (A) Multi-
ple lung cysts found on chest 
computed tomography. (B) A right
renal cyst found on abdominal 
sonography.
gene product. Based on this, it is possible to accurately 
diagnose BHDS.
His pneumothorax was treated with thoracostomy and 
pleurodesis, and active treatment was not required for the 
skin lesions, lung cysts and renal cyst. He is on regular 
follow-up because renal and colorectal cancer can occur 
in this syndrome.
DISCUSSION
BHDS was first described in 1977 by three Canadian 
physicians who studied a family with several members 
affected by multiple skin fibrofolliculomas, tricho-
discomas, and acrochordons
1. Fibrofolliculoma, histo-
logically verified, is one of the major features of this 
syndrome and can be accompanied by multiple lung Birt-Hogg-Dubé Syndrome, a Rare Case in Korea Confirmed by Genetic Analysis
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Table. 1. Diagnostic criteria for Birt-Hogg-Dubé syndrome
Panel: Diagnostic criteria for Birt-Hogg-Dubé syndrome (BHD; patients should fulfill one major or two minor criteria for diagnosis)
Major criteria
At least five fibrofolliculomas or trichodiscomas, at least one histologically confirmed, of adult onset*
Pathogenic FLCN germline mutation
Minor criteria
Multiple lung cysts: bilateral basally located lung cysts with no other apparent cause, with or without spontaneous primary 
pneumothorax
Renal cancer: early onset (<50 years) or multifocal or bilateral renal cancer, or renal cancer of mixed chromophobe and oncocytic
histology
A first-degree relative with BHD
*Fibrofolliculoma and trichodiscoma are two possible presentations of the same lesion?for the diff erential diagnosis, angiofibroma 
in tuberous sclerosis should be considered. Childhood-onset familial fi brofolliculoma or trichodiscoma without other syndromic features 
might be a distinct entity.
cysts, spontaneous pneumothorax and renal cancer. The 
disease is caused by a mutation of the FLCN gene, which 
is located in chromosome position 17p11.2 and encodes 
for the folliculin protein. The function of this protein is 
predicted to exhibit tumor-suppressor activity but this is 
largely unverified
2-4. Although the incidence is not yet 
established, about 200 families with BHDS containing 
pathogenic  FLCN mutations have been reported world-
wide
2. Among these, an apparent difference in mutations 
were found, which include insertion, deletion, inac-
tivating frameshift and nonsense mutations
1,4. Because no 
genotype-phenotype correlation has been found to date 
and clinical expression is widely variable, BHDS is most 
likely under-diagnosed
2,5. 
Menko et al.
2 suggested diagnostic criteria for BHDS 
(Table 1). Our patient had more than 10 fibrofolliculomas 
on the face, which were confirmed histologically, as well 
as multiple lung cysts with recurrent spontaneous pneu-
mothorax. In addition, molecular analysis showed a mu-
tation in the folliculin gene, c.1285dupC (p.H429Pfs* 27), 
which had been reported previously
6. Therefore, he 
fulfilled two major criteria and one minor criteria for 
BHDS diagnosis. 
Because of a 7-fold increased risk of developing renal 
tumors in BHDS-affected individuals, surveillance for 
renal cancer is indicated
7. However, there are no 
established guidelines on what the optimum age is to start 
surveillance, the methods of examination, and the interval 
between examinations. Possible methods include ultra-
sonography, computed tomography, and magnetic reso-
nance imaging. Our patient was advised to be screened 
every 6 to 12 months for renal cancer including consul-
tation with a nephrologist.  
Also, differential diagnosis is important, as firm, dome- 
shaped papules that appear predominantly in the head 
and neck region can be seen in several tumor-related 
syndromes. These include angiofibromas in tuberous 
sclerosis, trichilemmomas in Cowden disease, and tricho-
epitheliomas in Brooke-Spiegler syndrome, etc
8. Histo-
logic examination of the lesions and thorough evaluation 
for concomitant systemic disease can differentiate BHDS 
from other disorders. 
Management strategies currently are symptomatic and 
preventive
2. Treatment for fibrofolliculomas using an 
erbium-YAG or fractional CO2 laser provides temporary 
improvement
9-11. Individuals exposed to large ambient 
pressure differences such as piloting and deep-sea diving 
should be assessed by a pulmonary physician. Smoking, 
which is an important risk factor for both spontaneous 
pneumothorax and renal cancer, should be strongly 
discouraged. Further investigations such as the molecular 
analysis of the FLCN gene for patients suspected of BHDS 
and their 1st degree families should be strongly en-
courage. 
In this study, we experienced a case of BHDS confirmed 
by genetic analysis, which has rarely been reported in 
Korea. Based on this case, it is important that physicians 
recognize facial papules that can be developed concur-
rently with systemic disease and conduct adequate studies 
to detect other features of the disease.
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